Report Detail

The global extracellular matrix market is expected to reach US$ 47.46 Mn in 2027 from US$ 24.30 Mn in 2018. The extracellular matrix market is estimated to grow with a CAGR of 8.2% from 2019-2027.
The market is driven by the factors such as, significantly increasing incidences of trauma and cardiovascular diseases, increasing vascular reconstruction procedures and increasing product launches are likely to drive the growth of the extracellular matrix market. However, challenges during the usage of decellularized extracellular matrix is major challenge for the growth of the extracellular matrix market.
The significantly rising incidences of the orthopedic trauma conditions and cardiovascular diseases among others are the leading factors for the market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others.
Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantage of the extracellular matrix serve the demand of the patients. However, technically advanced procedures requires higher care cost, for instance, according to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs. Therefore, the higher expenditures are also expected to drive the growth of market and provide better services.
In addition, the surgical orthopedic treatment including joint arthroscopy, fracture repair, general repair procedures on damaged muscle or tendon and corrective surgery requires extracellular matrix. These conditions are generally caused due to the sports and road accidents. For instance, according to the National Safety Council, in 2015, in the US, population in the age group from 5 to 14 accounted to 51% of total football injuries treated in emergency rooms. Thus, owing to the above mentioned factors the market is likely to propel during the forecast period.
Global extracellular matrix market was segmented by application and raw material. On the basis of the application the market is segmented as vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. Based on the raw material the extracellular matrix market is segmented into bovine, porcine and others. Among the application segment soft tissue repair market held the largest market share. And on the basis of the raw material porcine segment held the largest market share.
Some of the major primary and secondary sources included in the report for the extracellular matrix market are World Health Organization, Arthroscopy and Sports Medicine Society, American Society of Orthopedic Surgeons, American Society of Plastic Surgeons, Biological Sciences Research Council, Center for Commercialization of Regenerative Medicine, Centers for Disease Control and Prevention, Engineering and Physical Sciences Research Council, International Society of Aesthetic Plastic Surgery, Natural Sciences and Engineering Research Council of Canada among the others.


1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Extracellular Matrix Market – By Application
    • 1.3.2 Global Extracellular Matrix Market – By Raw Material
    • 1.3.3 Global Extracellular Matrix Market – By Geography

2. Global Extracellular Matrix Market – Key Takeaways

    3. Research Methodology

    • 3.1 Coverage
    • 3.2 Secondary Research
    • 3.3 Primary Research

    4. Global Extracellular Matrix– Market Landscape

    • 4.1 Overview
    • 4.2 PEST Analysis
      • 4.2.1 North America – Pest Analysis
      • 4.2.2 Europe – Pest Analysis
      • 4.2.3 Asia Pacific– Pest Analysis
      • 4.2.4 Middle East And Africa– Pest Analysis
      • 4.2.5 South & Central America – Pest Analysis

    5. Global Extracellular Matrix Market – Key Industry Dynamics

    • 5.1 Key Market Drivers
      • 5.1.1 Significantly Increasing Incidences Of Trauma And Cardiovascular Diseases
      • 5.1.2 Increasing Vascular Reconstruction Procedures
      • 5.1.3 Increasing Product Launches
    • 5.2 Key Market Challenge
      • 5.2.1 Challenges During The Usage Of Decellularized Extracellular Matrix
    • 5.3 Key Market Opportunities
      • 5.3.1 Opportunities To Treat Cancer
      • 5.3.2 Growth Opportunities In The Developing Nations
    • 5.4 Impact Analysis Of Drivers And Challenges

    6. Extracellular Matrix Market – Global Analysis

    • 6.1 Global Extracellular Matrix Market Revenue Forecasts And Analysis
    • 6.2 Global Extracellular Matrix Market, By Geography - Forecasts And Analysis
    • 6.3 Performance/ Positioning Of Key Players
      • 6.3.1 Smith & Nephew
      • 6.3.2 Dsm Biomedical

    7. Extracellular Matrix Market Analysis And Forecasts To 2027 – Application

    • 7.1 Overview
    • 7.2 Global Extracellular Matrix Market Share By Application 2018 & 2027 (%)
    • 7.3 Vascular Repair And Reconstruction Market
      • 7.3.1 Overview
      • 7.3.2 Vascular Repair And Reconstruction Market Revenue And Forecast To 2027 (US$ Mn)
    • 7.4 Dural Repair Market
      • 7.4.1 Overview
      • 7.4.2 Dural Repair Market Revenue And Forecast To 2027 (US$ Mn)
    • 7.5 Wound Healing Market
      • 7.5.1 Overview
      • 7.5.2 Wound Healing Market Revenue And Forecast To 2027 (US$ Mn)
    • 7.6 Cardiac Repair Market
      • 7.6.1 Overview
      • 7.6.2 Cardiac Repair Market Revenue And Forecast To 2027 (US$ Mn)
    • 7.7 Pericardial Repair Market
      • 7.7.1 Overview
      • 7.7.2 Pericardial Repair Market Revenue And Forecast To 2027 (US$ Mn)
    • 7.8 Soft Tissue Repair Market
      • 7.8.1 Overview
      • 7.8.2 Soft Tissue Repair Market Revenue And Forecast To 2027 (US$ Mn)

    8. Extracellular Matrix Market Analysis And Forecasts To 2027 – Raw Material

    • 8.1 Overview
    • 8.2 Global Extracellular Matrix Market Share By Raw Material 2018 & 2027 (%)
    • 8.3 Bovine Market
      • 8.3.1 Overview
      • 8.3.2 Bovine Market Revenue And Forecast To 2027 (US$ Mn)
    • 8.4 Porcine Market
      • 8.4.1 Overview
      • 8.4.2 Porcine Market Revenue And Forecast To 2027 (US$ Mn)
    • 8.5 Others Market
      • 8.5.1 Overview
      • 8.5.2 Others Market Revenue And Forecast To 2027 (US$ Mn)

    9. Extracellular Matrix Market Revenue And Forecasts To 2027 – Geographical Analysis

    • 9.1 North America Extracellular Matrix Market
      • 9.1.1 Overview
      • 9.1.2 North America Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
      • 9.1.3 North America Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
      • 9.1.4 North America Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.1.5 North America Extracellular Matrix Market Revenue And Forecasts To 2027, By Country (%)
      • 9.1.6 US Extracellular Matrix Market
        • 9.1.6.1 US Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.1.6.2 US Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.1.6.3 US Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.1.7 Canada Extracellular Matrix Market
        • 9.1.7.1 Canada Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.1.7.2 Canada Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.1.7.3 Canada Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.1.8 Mexico Extracellular Matrix Market
        • 9.1.8.1 Mexico Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.1.8.2 Mexico Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.1.8.3 Mexico Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
    • 9.2 Europe Extracellular Matrix Market
      • 9.2.1 Overview
      • 9.2.2 Europe Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
      • 9.2.3 Europe Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
      • 9.2.4 Europe Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.2.5 Europe Extracellular Matrix Market Revenue And Forecasts To 2027, By Country (%)
      • 9.2.6 Germany Extracellular Matrix Market
        • 9.2.6.1 Germany Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.2.6.2 Germany Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.2.6.3 Germany Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.2.7 UK Extracellular Matrix Market
        • 9.2.7.1 UK Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.2.7.2 UK Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.2.7.3 UK Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.2.8 France Extracellular Matrix Market
        • 9.2.8.1 France Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.2.8.2 France Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.2.8.3 France Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.2.9 Spain Extracellular Matrix Market
        • 9.2.9.1 Spain Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.2.9.2 Spain Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.2.9.3 Spain Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.2.10 Italy Extracellular Matrix Market
        • 9.2.10.1 Italy Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.2.10.2 Italy Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.2.10.3 Italy Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
    • 9.3 Asia Pacific Extracellular Matrix Market
      • 9.3.1 Overview
      • 9.3.2 Asia Pacific Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
      • 9.3.3 Asia Pacific Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
      • 9.3.4 Asia Pacific Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.3.5 Asia Pacific Extracellular Matrix Market Revenue And Forecasts To 2027, By Country (%)
      • 9.3.6 China Extracellular Matrix Market
        • 9.3.6.1 China Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.3.6.2 China Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.3.6.3 China Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.3.7 Japan Extracellular Matrix Market
        • 9.3.7.1 Japan Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.3.7.2 Japan Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.3.7.3 Japan Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.3.8 India Extracellular Matrix Market
        • 9.3.8.1 India Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.3.8.2 India Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.3.8.3 India Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.3.9 Australia Extracellular Matrix Market
        • 9.3.9.1 Australia Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.3.9.2 Australia Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.3.9.3 Australia Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.3.10 South Korea Extracellular Matrix Market
        • 9.3.10.1 South Korea Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.3.10.2 South Korea Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.3.10.3 South Korea Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
    • 9.4 Middle East And Africa Extracellular Matrix Market
      • 9.4.1 Overview
      • 9.4.2 Middle East And Africa Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
      • 9.4.3 Middle East And Africa Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
      • 9.4.4 Middle East And Africa Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.4.5 Middle East And Africa Extracellular Matrix Market Revenue And Forecasts To 2027, By Country (%)
      • 9.4.6 UAE Extracellular Matrix Market
        • 9.4.6.1 Uae Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.4.6.2 UAE Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.4.6.3 UAE Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.4.7 Saudi Arabia Extracellular Matrix Market
        • 9.4.7.1 Saudi Arabia Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.4.7.2 Saudi Arabia Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.4.7.3 Saudi Arabia Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.4.8 South Africa Extracellular Matrix Market
        • 9.4.8.1 South Africa Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.4.8.2 South Africa Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.4.8.3 South Africa Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
    • 9.5 South And Central America Extracellular Matrix Market
      • 9.5.1 Overview
      • 9.5.2 South And Central America Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
      • 9.5.3 South And Central America Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
      • 9.5.4 South And Central America Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.5.5 South And Central America Extracellular Matrix Market Revenue And Forecasts To 2027, By Country (%)
      • 9.5.6 Brazil Extracellular Matrix Market
        • 9.5.6.1 Brazil Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.5.6.2 Brazil Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.5.6.3 Brazil Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)
      • 9.5.7 Argentina Extracellular Matrix Market
        • 9.5.7.1 Argentina Extracellular Matrix Market Revenue And Forecasts To 2027 (US$ Thousand)
        • 9.5.7.2 Argentina Extracellular Matrix Market Revenue And Forecasts To 2027, By Application (US$ Thousand)
        • 9.5.7.3 Argentina Extracellular Matrix Market Revenue And Forecasts To 2027, By Raw Material (US$ Thousand)

      10. Extracellular Matrix Market – Industry Landscape

      • 10.1 Overview
      • 10.2 Growth Strategies In The Extracellular Matrix Market, 2015-2019
      • 10.3 Organic Growth Strategies
        • 10.3.1 Overview
        • 10.3.2 Product Launch
        • 10.3.3 Expansion
        • 10.3.4 Product Approval
      • 10.4 Inorganic Growth Strategies
        • 10.4.1 Overview
        • 10.4.2 Agreement
        • 10.4.3 Acquisition
        • 10.4.4 Partnership

      11. Extracellular Matrix Market–Key Company Profiles

      • 11.1 Admedus
        • 11.1.1 Key Facts
        • 11.1.2 Business Description
        • 11.1.3 Financial Overview
        • 11.1.4 Product Portfolio
        • 11.1.5 SWOT Analysis
        • 11.1.6 Key Developments
      • 11.2 Coloplast Group
        • 11.2.1 Key Facts
        • 11.2.2 Business Description
        • 11.2.3 Financial Overview
        • 11.2.4 Product Portfolio
        • 11.2.5 SWOT Analysis
        • 11.2.6 Key Developments
      • 11.3 Merck Kgaa
        • 11.3.1 Key Facts
        • 11.3.2 Business Description
        • 11.3.3 Financial Overview
        • 11.3.4 Product Portfolio
        • 11.3.5 SWOT Analysis
        • 11.3.6 Key Developments
      • 11.4 Smith & Nephew
        • 11.4.1 Key Facts
        • 11.4.2 Business Description
        • 11.4.3 Financial Overview
        • 11.4.4 Product Portfolio
        • 11.4.5 SWOT Analysis
        • 11.4.6 Key Developments
      • 11.5 Mtf Biologics
        • 11.5.1 Key Facts
        • 11.5.2 Business Description
        • 11.5.3 Financial Overview
        • 11.5.4 Product Portfolio
        • 11.5.5 SWOT Analysis
        • 11.5.6 Key Developments
      • 11.6 Lattice Biologics Ltd.
        • 11.6.1 Key Facts
        • 11.6.2 Business Description
        • 11.6.3 Financial Information
        • 11.6.4 Product Portfolio
        • 11.6.5 SWOT Analysis
        • 11.6.6 Key Developments
      • 11.7 Cook Biotech, Inc.
        • 11.7.1 Key Facts
        • 11.7.2 Business Description
        • 11.7.3 Financial Overview
        • 11.7.4 Product Portfolio
        • 11.7.5 SWOT Analysis
        • 11.7.1 Key Developments
      • 11.8 Medtronic
        • 11.8.1 Key Facts
        • 11.8.2 Business Description
        • 11.8.3 Financial Information
        • 11.8.4 Product Portfolio
        • 11.8.5 SWOT Analysis
        • 11.8.6 Key Developments
      • 11.9 Aziyo Biologics, Inc.
        • 11.9.1 Key Facts
        • 11.9.2 Business Description
        • 11.9.3 Financial Information
        • 11.9.4 Product Portfolio
        • 11.9.5 SWOT Analysis
        • 11.9.6 Key Developments
      • 11.10 Dsm Biomedical
        • 11.10.1 Key Facts
        • 11.10.2 Business Description
        • 11.10.3 Financial Overview
        • 11.10.4 Product Portfolio
        • 11.10.5 SWOT Analysis
        • 11.10.6 Key Developments

      12. Appendix

      • 12.1 About The Insight Partners

    Summary:
    Get latest Market Research Reports on Extracellular Matrix . Industry analysis & Market Report on Extracellular Matrix is a syndicated market report, published as Extracellular Matrix Market to 2027 - Global Analysis and Forecasts By Application (Vascular Repair and Reconstruction, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, Soft Tissue Repair); Raw Material (Bovine, Porcine, Other Raw Material)and Geography. It is complete Research Study and Industry Analysis of Extracellular Matrix market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,550.00
    $6,550.00
    $8,550.00
    3,589.95
    5,167.95
    6,745.95
    4,317.95
    6,215.95
    8,113.95
    710,300.50
    1,022,520.50
    1,334,740.50
    384,338.50
    553,278.50
    722,218.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report